English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/128923
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Acid ceramidase as a therapeutic target in metastatic prostate cancer

AuthorsCamacho, Luz ; Meca-Cortés, Óscar ; Abad, José Luis ; García, Simón; Rubio, Nuria; Celià-Terrassa, Toni ; Cingolani, Francesca; Blanco, Jerónimo ; Delgado Cirilo, Antonio ; Casas, Josefina ; Thomson, Timothy M.
KeywordsInhibitors
Ceramide
Metastasis
Issue Date19-Feb-2013
PublisherAmerican Society for Biochemistry and Molecular Biology
CitationJournal of Lipid Research 54(5): 1207-1220 (2013)
AbstractAcid ceramidase (AC) catalyzes the hydrolysis of ceramide into sphingosine, in turn a substrate of sphingosine kinases that catalyze its conversion into the mitogenic sphingosine- 1-phosphate. AC is expressed at high levels in several tumor types and has been proposed as a cancer therapeutic target. Using a model derived from PC-3 prostate cancer cells, the highly tumorigenic, metastatic, and chemoresistant clone PC-3/Mc expressed higher levels of the AC ASAH1 than the nonmetastatic clone PC-3/S. Stable knockdown of ASAH1 in PC-3/Mc cells caused an accumulation of ceramides, inhibition of clonogenic potential, increased requirement for growth factors, and inhibition of tumorigenesis and lung metastases. We developed de novo ASAH1 inhibitors, which also caused a dose-dependent accumulation of ceramides in PC-3/Mc cells and inhibited their growth and clonogenicity. Finally, immunohistochemical analysis of primary prostate cancer samples showed that higher levels of ASAH1 were associated with more advanced stages of this neoplasia. These observations confirm ASAH1 as a therapeutic target in advanced and chemoresistant forms of prostate cancer and suggest that our new potent and specific AC inhibitors could act by counteracting critical growth properties of these highly aggressive tumor cells. Copyright © 2013 by the American Society for Biochemistry and Molecular Biology, Inc.
Publisher version (URL)http://dx.doi.org/10.1194/jlr.M032375
URIhttp://hdl.handle.net/10261/128923
DOI10.1194/jlr.M032375
Identifiersdoi: 10.1194/jlr.M032375
issn: 0022-2275
Appears in Collections:(IQAC) Artículos
(CIC) Artículos
(IBMB) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.